130 related articles for article (PubMed ID: 38631143)
1. Re-exploration of immunotherapy targeting EMT of hepatocellular carcinoma: Starting from the NF-κB pathway.
Wang S; He Y; Wang J; Luo E
Biomed Pharmacother; 2024 May; 174():116566. PubMed ID: 38631143
[TBL] [Abstract][Full Text] [Related]
2. Mannose-mediated inhibitory effects of PA-MSHA on invasion and metastasis of hepatocellular carcinoma via EGFR/Akt/IκBβ/NF-κB pathway.
Li T; Dong ZR; Guo ZY; Wang CH; Zhi XT; Zhou JW; Li DK; Chen ZT; Chen ZQ; Hu SY
Liver Int; 2015 Apr; 35(4):1416-29. PubMed ID: 25066210
[TBL] [Abstract][Full Text] [Related]
3. HAX-1 promotes the migration and invasion of hepatocellular carcinoma cells through the induction of epithelial-mesenchymal transition via the NF-κB pathway.
Hu YL; Feng Y; Ma P; Wang F; Huang H; Guo YB; Li P; Mao QS; Xue WJ
Exp Cell Res; 2019 Aug; 381(1):66-76. PubMed ID: 31047882
[TBL] [Abstract][Full Text] [Related]
4. Epithelial-Mesenchymal Transformation Promotes the Progression of Hepatocellular Carcinoma through NF-κB/MMP9 Axis.
Li J; Cai Q; Wang Z; Wang L; Yang G; Zhang Z; Ge N; Hu S; Bai T
Discov Med; 2024 Apr; 36(183):666-677. PubMed ID: 38665016
[TBL] [Abstract][Full Text] [Related]
5. Lenvatinib Synergistically Promotes Radiation Therapy in Hepatocellular Carcinoma by Inhibiting Src/STAT3/NF-κB-Mediated Epithelial-Mesenchymal Transition and Metastasis.
Weng YS; Chiang IT; Tsai JJ; Liu YC; Hsu FT
Int J Radiat Oncol Biol Phys; 2023 Mar; 115(3):719-732. PubMed ID: 36245124
[TBL] [Abstract][Full Text] [Related]
6. NKILA, a prognostic indicator, inhibits tumor metastasis by suppressing NF-κB/Slug mediated epithelial-mesenchymal transition in hepatocellular carcinoma.
Chen R; Cheng Q; Owusu-Ansah KG; Song G; Jiang D; Zhou L; Xu X; Wu J; Zheng S
Int J Biol Sci; 2020; 16(3):495-503. PubMed ID: 32015685
[TBL] [Abstract][Full Text] [Related]
7. CCL18/PITPNM3 enhances migration, invasion, and EMT through the NF-κB signaling pathway in hepatocellular carcinoma.
Lin Z; Li W; Zhang H; Wu W; Peng Y; Zeng Y; Wan Y; Wang J; Ouyang N
Tumour Biol; 2016 Mar; 37(3):3461-8. PubMed ID: 26449829
[TBL] [Abstract][Full Text] [Related]
8. Apigenin inhibits NF-κB and snail signaling, EMT and metastasis in human hepatocellular carcinoma.
Qin Y; Zhao D; Zhou HG; Wang XH; Zhong WL; Chen S; Gu WG; Wang W; Zhang CH; Liu YR; Liu HJ; Zhang Q; Guo YQ; Sun T; Yang C
Oncotarget; 2016 Jul; 7(27):41421-41431. PubMed ID: 27203387
[TBL] [Abstract][Full Text] [Related]
9. MiR-491 attenuates cancer stem cells-like properties of hepatocellular carcinoma by inhibition of GIT-1/NF-κB-mediated EMT.
Yang X; Ye J; Yan H; Tang Z; Shen J; Zhang J; Yang L
Tumour Biol; 2016 Jan; 37(1):201-9. PubMed ID: 26188902
[TBL] [Abstract][Full Text] [Related]
10. Monoacylglycerol lipase promotes progression of hepatocellular carcinoma via NF-κB-mediated epithelial-mesenchymal transition.
Zhu W; Zhao Y; Zhou J; Wang X; Pan Q; Zhang N; Wang L; Wang M; Zhan D; Liu Z; He X; Ma D; Liu S; Wang L
J Hematol Oncol; 2016 Nov; 9(1):127. PubMed ID: 27884159
[TBL] [Abstract][Full Text] [Related]
11. AQP5 promotes hepatocellular carcinoma metastasis via NF-κB-regulated epithelial-mesenchymal transition.
He Z; Dong W; Hu J; Ren X
Biochem Biophys Res Commun; 2017 Aug; 490(2):343-348. PubMed ID: 28619511
[TBL] [Abstract][Full Text] [Related]
12. RUFY3 promotes the progression of hepatocellular carcinoma through activating NF-κB-mediated epithelial-mesenchymal transition.
Zhang Y; Ni W; Qin L
Aging (Albany NY); 2021 Sep; 13(17):21283-21293. PubMed ID: 34510031
[TBL] [Abstract][Full Text] [Related]
13. Disulfiram combined with copper inhibits metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma through the NF-κB and TGF-β pathways.
Li Y; Wang LH; Zhang HT; Wang YT; Liu S; Zhou WL; Yuan XZ; Li TY; Wu CF; Yang JY
J Cell Mol Med; 2018 Jan; 22(1):439-451. PubMed ID: 29148232
[TBL] [Abstract][Full Text] [Related]
14. ZnAs@SiO
Huang Y; Zhou B; Luo H; Mao J; Huang Y; Zhang K; Mei C; Yan Y; Jin H; Gao J; Su Z; Pang P; Li D; Shan H
Theranostics; 2019; 9(15):4391-4408. PubMed ID: 31285768
[No Abstract] [Full Text] [Related]
15. Novel ADAM-17 inhibitor ZLDI-8 inhibits the metastasis of hepatocellular carcinoma by reversing epithelial-mesenchymal transition in vitro and in vivo.
Lu HY; Chu HX; Tan YX; Qin XC; Liu MY; Li JD; Ren TS; Zhang YS; Zhao QC
Life Sci; 2020 Mar; 244():117343. PubMed ID: 31978449
[TBL] [Abstract][Full Text] [Related]
16. Reciprocal activation between ATPase inhibitory factor 1 and NF-κB drives hepatocellular carcinoma angiogenesis and metastasis.
Song R; Song H; Liang Y; Yin D; Zhang H; Zheng T; Wang J; Lu Z; Song X; Pei T; Qin Y; Li Y; Xie C; Sun B; Shi H; Li S; Meng X; Yang G; Pan S; Zhu J; Qi S; Jiang H; Zhang Z; Liu L
Hepatology; 2014 Nov; 60(5):1659-73. PubMed ID: 25042864
[TBL] [Abstract][Full Text] [Related]
17. The novel glycyrrhetinic acid-tetramethylpyrazine conjugate TOGA induces anti-hepatocarcinogenesis by inhibiting the effects of tumor-associated macrophages on tumor cells.
Wang X; Tan Y; Zhang Y; Xu Z; Xu B; Lei H; Ding C; Cheng S; Wang X; Wei P; Wang Z; Mao Q; Ai C; Hua Q
Pharmacol Res; 2020 Nov; 161():105233. PubMed ID: 33031908
[TBL] [Abstract][Full Text] [Related]
18. MAP4K4 promotes epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma.
Feng XJ; Pan Q; Wang SM; Pan YC; Wang Q; Zhang HH; Zhu MH; Zhang SH
Tumour Biol; 2016 Aug; 37(8):11457-67. PubMed ID: 27010469
[TBL] [Abstract][Full Text] [Related]
19. MiR-16 inhibits hepatocellular carcinoma progression by targeting FEAT through NF-κB signaling pathway.
Su XF; Li N; Meng FL; Chu YL; Li T; Gao XZ
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10274-10282. PubMed ID: 31841182
[TBL] [Abstract][Full Text] [Related]
20. Dihydropyrimidine dehydrogenase predicts survival and response to interferon-α in hepatocellular carcinoma.
Zhu WP; Liu ZY; Zhao YM; He XG; Pan Q; Zhang N; Zhou JM; Wang LR; Wang M; Zhan DH; Ma DN; Wang L
Cell Death Dis; 2018 Jan; 9(2):69. PubMed ID: 29358721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]